LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
出版年份 2016 全文链接
标题
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
作者
关键词
Liraglutide, Cardiovascular, Type 2 diabetes, LEADER, Cardiometabolic, Obesity, Overweight
出版物
Cardiovascular Diabetology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-12
DOI
10.1186/s12933-016-0341-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
- (2015) Sanjoy K Paul et al. Cardiovascular Diabetology
- Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes
- (2015) Lawrence Blonde et al. Cardiovascular Diabetology
- Association of obesity with glucose, blood pressure, and lipid goals attainment in patients with concomitant diabetes and hypertension
- (2015) Ping Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
- (2015) M. A. Bethel et al. DIABETES OBESITY & METABOLISM
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010
- (2014) Elizabeth Selvin et al. ANNALS OF INTERNAL MEDICINE
- Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage
- (2014) Luis A Vázquez et al. BMC Cardiovascular Disorders
- Is There a Paradox in Obesity?
- (2014) Akankasha Goyal et al. Cardiology in Review
- Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
- (2014) Chun-Jun Li et al. Cardiovascular Diabetology
- 8. Cardiovascular Disease and Risk Management
- (2014) DIABETES CARE
- Ethnic-Specific Obesity Cutoffs for Diabetes Risk: Cross-sectional Study of 490,288 UK Biobank Participants
- (2014) Uduakobong E. Ntuk et al. DIABETES CARE
- Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008
- (2014) N. R. V. Jones et al. DIABETIC MEDICINE
- Ethnicity-specific obesity cut-points in the development of Type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom
- (2014) T. Tillin et al. DIABETIC MEDICINE
- Gender differences and patterns of cardiovascular risk factors in Type 1 and Type 2 diabetes: a population-based analysis from a Scottish region
- (2014) A. Collier et al. DIABETIC MEDICINE
- Metabolic mediators of body-mass index and cardiovascular risk
- (2014) David Wormser et al. LANCET
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- Association between Obesity and Therapeutic Goal Attainment in Patients with Concomitant Hypertension and Dyslipidemia
- (2014) Ishveen Chopra et al. POSTGRADUATE MEDICINE
- Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study
- (2014) Louise G H Goh et al. BMJ Open
- Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
- (2013) Steven P. Marso et al. AMERICAN HEART JOURNAL
- Important Treatment Gaps in Vascular Protection for the Elderly After Type 2 Diabetes Therapy Initiation
- (2013) Line Guénette et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
- (2013) Michael E. Farkouh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patients With Type 2 Diabetes Show a Greater Decline in Muscle Mass, Muscle Strength, and Functional Capacity With Aging
- (2013) Marika Leenders et al. Journal of the American Medical Directors Association
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
- (2013) Marjorie Bastien et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation
- (2012) Ina-Maria Rückert et al. Cardiovascular Diabetology
- Predictors of Mortality Over 8 Years in Type 2 Diabetic Patients: Translating Research Into Action for Diabetes (TRIAD)
- (2012) L. N. McEwen et al. DIABETES CARE
- Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
- (2012) K. Niswender et al. DIABETES OBESITY & METABOLISM
- Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
- (2011) I. D. Caterson et al. DIABETES OBESITY & METABOLISM
- Do men develop type 2 diabetes at lower body mass indices than women?
- (2011) J. Logue et al. DIABETOLOGIA
- The global obesity pandemic: shaped by global drivers and local environments
- (2011) Boyd A Swinburn et al. LANCET
- Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies
- (2011) The Emerging Risk Factors Collaboration LANCET
- Relation Between Obesity and the Attainment of Optimal Blood Pressure and Lipid Targets in High Vascular Risk Outpatients
- (2010) Vineet Bhan et al. AMERICAN JOURNAL OF CARDIOLOGY
- The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period
- (2010) Peter Weeke et al. BMC Endocrine Disorders
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Obesity and Cardiovascular Disease
- (2009) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationships of Obesity and Fat Distribution With Atherothrombotic Risk Factors: Baseline Results From the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
- (2009) Jeanine B. Albu et al. Obesity
- Statins and cardioprotection — More than just lipid lowering?
- (2009) Andrew Ludman et al. PHARMACOLOGY & THERAPEUTICS
- Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity: The Framingham Heart Study
- (2008) E. A. Molenaar et al. DIABETES CARE
- The relationship of body fat to metabolic disease: Influence of sex and ethnicity
- (2008) Anne E. Sumner Gender Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation